Godavari Drugs530317Preferential allotment

Board approves allotment of 7,86,690 equity shares to promoters on conversion of warrants

Board of Godavari Drugs met on 05.11.2026 and approved allotment of 7,86,690 equity shares to the Promoter Category.

By ScoutQuest · Thu 5 Nov 2026, 6:46 PM IST · 2 min read

75%Balance received as share of issue price per warrant

Balance received as share of issue price per warrant: 75%.

Shares allotted on warrant conversion: 7,86,690 equity shares to the Promoter Category
Issue price per share: Rs. 89/- per share, including a premium of Rs. 79/- each
Balance amount received: ~Rs. 5.25 crore (75% of issue price per warrant); paid-up capital rises to Rs. 11,70,08,150/- in 1,17,00,815 shares

The Board of Godavari Drugs Ltd, at its meeting held on 05.11.2026, considered and approved the allotment of 7,86,690 equity shares of face value Rs. 10/- each, fully paid up.
These shares were allotted on conversion of 7,86,690 warrants that had been issued on a preferential basis to the "Promoters Category".
The allotment followed receipt of the balance amount of ~Rs. 5.25 crore, stated to be 75% of the issue price per warrant, from the allottees.

Issue price: Rs. 89/- per equity share, which includes a premium of Rs. 79/- per share.
The update describes the amount received as Rs. 5,25,11,557.5/-, worked out as 7,86,690 shares multiplied by Rs. 66.75/- paid per share.
Mode of issue: preferential allotment on a private placement basis, through conversion of warrants into equity shares.

All nine allottees fall in the Promoter Category.
Ghanshyam Jaju: 60,000 shares; Kamala Jaju: 1,00,000; Mohit Jaju: 1,33,355; Priyanka Jaju: 33,334; Ieshir Jaju: 66,667.
Mukund Kakani: 1,56,334 shares; Sushma Kakani: 1,41,000; Tanushree Kakani: 46,000; Aksheit Kakani: 50,000.
Total: 7,86,690 shares.

Before the allotment: paid-up equity share capital of Rs. 10,91,41,250/- comprising 1,09,14,125 equity shares of Rs. 10/- each.
After the allotment: paid-up equity share capital of Rs. 11,70,08,150/- comprising 1,17,00,815 equity shares of Rs. 10/- each.
In simple terms, the company has issued new shares to promoter-group investors, so the total number of shares in the company has gone up by 7,86,690.

This is the second leg of a preferential issue that was already structured as warrants; the shares now come into existence because the allottees exercised conversion and paid the balance money.
Because the shares are issued to the promoter category, promoter shareholding in the company changes with this allotment.
New shares being issued means the total share count rises, so each existing share represents a slightly smaller slice of the company than before.
The update is a disclosure of the allotment and the resulting capital structure; the allottee list and the post-allotment capital figures are the numbers to track.

Rs. 11,70,08,150/-+7.2%

BeforeRs. 10,91,41,250/-AfterRs. 11,70,08,150/-

Paid-up equity share capital allotment: Rs. 10,91,41,250/- (Before) and Rs. 11,70,08,150/- (After).

Also from Godavari Drugs

16 Oct 2026

14 Oct 2026